ADT (NYSE:ADT) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $16.00 price target on the stock.
Akebia Therapeutics (NASDAQ:AKBA) had its buy rating reaffirmed by analysts at Mizuho. Mizuho currently has a $24.00 price target on the stock. The analysts wrote, “We had a chance to catch up with CEO John Butler yesterday at the Bio CEO & Investor Conference. We summarize our key takeaways below. Akebia also provided an update on the Vadadustat development program yesterday morning including an expansion of the ongoing phase 2 For2ward and phase 3 Trilo2gy trials in collaboration with Otsuka (TYO:4578, Non rated). While this will delay the timeline for topline data in both programs, we see it as a positive overall as the company will now incorporate additional relevant endpoints with a greater number of patients for better positioning in commercialization. The timeline for data-readouts in the two pivotal Pro2tect and Inno2vate trials remains unchanged.””
Boliden (OTCMKTS:BDNNF) was downgraded by analysts at UBS Group AG from a neutral rating to a sell rating.
BP (NYSE:BP) was downgraded by analysts at Morgan Stanley from an overweight rating to an equal weight rating.
Concert Pharmaceuticals (NASDAQ:CNCE) had its hold rating reaffirmed by analysts at Mizuho. Mizuho currently has a $23.00 target price on the stock.
Eversource Energy (NYSE:ES) was downgraded by analysts at Morgan Stanley from an overweight rating to a hold rating. They currently have $60.00 price target on the stock, down from their previous price target of $63.00.
Fraport AG Frankfurt Arprt Svcs Wrldwde (FRA:FRA) had its buy rating reissued by analysts at JPMorgan Chase & Co..
Genpact (NYSE:G) had its buy rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $36.00 target price on the stock. The analysts wrote, “Foresi’s Take. Global Client BPO grew 15% y/y in 4Q17. However, Global Client growth was down from the prior-quarter level (+12% vs. 13%), but offset declines at GE enough to drive total revenues above Street estimates. Digital continues to be a key driver, as transformational services grew 25%, driven by demand for digital solutions (20% of Global Client revenue). Acquisitions are expected to add around 1% to 2018 revenues.””
Intercept Pharmaceuticals (NASDAQ:ICPT) had its market perform rating reaffirmed by analysts at Wells Fargo & Co. They currently have a $57.00 target price on the stock, down from their previous target price of $62.00.
Imperial Brands (OTCMKTS:IMBBY) was downgraded by analysts at Piper Jaffray Companies from an overweight rating to a hold rating.
The Coca-Cola (NYSE:KO) had its buy rating reiterated by analysts at Credit Suisse Group AG.
MAG Silver (NYSEAMERICAN:MAG) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $19.00 target price on the stock.
Insight Enterprises (NASDAQ:NSIT) had its buy rating reissued by analysts at B. Riley.
PennyMac Financial Services (NYSE:PFSI) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “PennyMac Financial Services, Inc. provides financial services primarily in the United States. The Company conducts its business in two segments: mortgage banking and investment management. Mortgage banking segment offers correspondent and retail lending businesses and loan servicing business. Investment management segment offers investment advisory and investment management services. PennyMac Financial Services, Inc. is headquartered in Moorpark, California. “
Panalpina Welt (OTCMKTS:PLWTY) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Panalpina Welttransport Holding AG engages in providing supply chain solutions. It offers freight shipping and supply chain management services. The Company transports freight by air and ship, and offers warehousing and distribution services. Panalpina’s air freight services include general, special, express, and intermodal services; and charter and emergency services. The company also offers ocean freight products comprising full container load, less-than-container load, and non-containerized load products, as well as various special services, such as dangerous goods handling, temperature controlled transportation, cargo insurance, letter of credit processing, certification and legalization of documents, food and drug administration filing, and advanced cargo information filing. It provides logistics services, including inbound, warehousing, production, distribution, and aftermarket services. Panalpina Welttransport Holding AG is headquartered in Basel, Switzerland. “
PROS (NYSE:PRO) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “PROS Holdings, Inc. a world leader in Pricing and Revenue Optimization Software, today announced that the underwriters of its initial public offering have exercised in full their over-allotment option. PROS is a leading provider of pricing and revenue optimization software products, specializing in price analytics, price execution, and price optimization. By using PROS’ software products, companies gain insight into their pricing strategies, identify pricing-based profit leaks, optimize their pricing decision making and improve their business processes and financial performance. PROS’ software products implement advanced pricing science, which includes operations research, forecasting and statistics. PROS also provides a range of services that include analyzing a company’s current pricing processes and implementing software products to improve pricing performance “
Phillips 66 Partners (NYSE:PSXP) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Phillips 66 Partners L.P is a downstream energy company. It operates in three segments: Refining and Marketing, Midstream and Chemicals. Refining and Marketing segment purchases, refines, markets and transports crude oil and petroleum products primarily in the United States, Europe and Asia. This segment also includes power generation operations. Midstream segment gathers, processes, transports and markets natural gas and transports, fractionates and markets natural gas liquids primarily in the United States. Chemicals segment manufactures and markets petrochemicals and plastics. Phillips 66 Partners L.P is headquartered in Houston, Texas. “
Portola Pharmaceuticals (NASDAQ:PTLA) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Portola Pharmaceuticals, Inc. is a biopharmaceutical company .It focuses on the development and commercialization of therapeutics for thrombosis, other hematologic disorders and inflammation. Portola Pharmaceuticals, Inc. is headquartered in South San Francisco, California. “
Restaurant Brands International (NYSE:QSR) (TSE:QSR) had its hold rating reissued by analysts at BMO Capital Markets.
Quantenna Communications (NASDAQ:QTNA) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $20.00 price target on the stock. The analysts wrote, “QTNA’s 4Q17 results and 1Q18 guidance were in line to slightly better than expected. We are encouraged that QTNA’s lead MSO has commenced the nationwide rollout of its DOCSIS 3.1 residential gateway platform featuring QTNA’s Wave 3 (10G) Wi-Fi chipset. We are also encouraged by the announcement that Canal + has recently commenced shipments of new STBs based on QTNA’s Wave 2 solution, which broadens the platform’s customer base. We continue to believe QTNA is the market leader in high performance Wi-Fi chipset solutions and is well positioned to benefit from increasing consumer demand for higher-bandwidth, more reliable Wi-Fi service. As such, we reiterate our Strong Buy rating and $20 price target. QTNA remains our top pick for 2018.””
US Foods (NYSE:USFD) had its outperform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $38.00 price target on the stock.
Energy Fuels (NYSEAMERICAN:UUUU) (TSE:EFR) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $5.00 price target on the stock.
Vertex Pharmaceuticals (NASDAQ:VRTX) had its hold rating reissued by analysts at HC Wainwright. They currently have a $103.00 price target on the stock. The analysts wrote, “Halts Triple Combination Trials in France as a Protest in Pricing Negotiations What’s new? We have recently learned via a twitter comment and associated article (http://bit.ly/2Bp7vL7) that Vertex has decided to discontinue the Phase 3 trials of its triple combination therapy for cystic fibrosis (CF) in France. During the Vertex 4Q earnings call, management identified the two second-generation correctors that would be added to the combination of tezacaftor/ivacaftor to formulate the triple combination. It appears that these trials will continue in the US and other parts of Europe but will now be excluding France due to an inability to reach reimbursement agreement with the French authorities for Orkambi. As mentioned in the article, this is a disappointment to the French CF patients that have been consistent participants in numerous trials to date and were eagerly awaiting more rapid access to what could be the most effective modulator treatment yet for CF.””
Weatherford International (NYSE:WFT) was downgraded by analysts at Barclays PLC from an overweight rating to a hold rating. The firm currently has $4.00 price target on the stock.
Receive News & Ratings for ADT Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADT Inc and related companies with MarketBeat.com's FREE daily email newsletter.